Sucrose Hydrolysis in a Continuous Packed-Bed Reactor with Auto-immobilise Aspergillus niger Biocatalyst Obtained by Solid-State Fermentation

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..

Invertase from Aspergillus niger C28B25 was produced by solid-state fermentation (SSF). Fermented solids were used directly as a biocatalyst for batch and continuous hydrolysis of sucrose in a packed-bed reactor under different operational conditions with various temperatures, sucrose concentrations, and feed flow rates. The SSF allowed obtaining a biocatalyst with an invertase activity of 82.2 U/g db. The biocatalyst maintained its activity in the range of 40 to 70 °C for at least 70 h of continuous operation. In a 20-mL packed bed reactor, the highest hydrolysis rate (12.3 g/g db h) was obtained at 40 °C with 2 M sucrose. Continuous hydrolysis in 20-mL and 200-mL reactors at 60 °C led to sucrose hydrolysis above 60% (8.5 residence times) and above 55% (4.5 residence times), respectively. The auto-immobilised biocatalyst produced by SSF without recovery, purification, and immobilisation stages offers an economical alternative for developing accessible biocatalysts that can be applied in batch or continuous sucrose hydrolysis processes. This study shows the potential of biocatalyst production by SSF for other enzymatic systems.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:194

Enthalten in:

Applied biochemistry and biotechnology - 194(2022), 3 vom: 26. März, Seite 1327-1339

Sprache:

Englisch

Beteiligte Personen:

Martínez-Ruiz, Antonio [VerfasserIn]
Tovar-Castro, Luz [VerfasserIn]
Aguilar, Cristóbal N [VerfasserIn]
Saucedo-Castañeda, Gerardo [VerfasserIn]
Favela-Torres, Ernesto [VerfasserIn]

Links:

Volltext

Themen:

β-Fructofuranosidases
Biocatalysis
Bioreactor stability
Invertase
Journal Article

Anmerkungen:

Date Completed 03.03.2022

Date Revised 03.03.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s12010-021-03737-z

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM332390942